JP MORGAN/PUT/BECTON DICKINSON AND CO./220/0.1/17.01.25 Share Price

Warrant

DE000JL1KNF4

Market Closed - Bid/Ask 12:47:33 17/06/2024 pm IST After market 11:42:20 pm
1.48 EUR -3.27% Intraday chart for JP MORGAN/PUT/BECTON DICKINSON AND CO./220/0.1/17.01.25 1.515 +2.36%
Current month-14.53%
3 months-12.57%
Date Price Change
17/24/17 1.48 -3.27%
14/24/14 1.53 +9.29%
13/24/13 1.4 -2.78%
12/24/12 1.44 +15.20%
11/24/11 1.25 -0.79%

Delayed Quote Börse Stuttgart

Last update June 17, 2024 at 12:47 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JL1KNF
ISINDE000JL1KNF4
Date issued 05/04/2023
Strike 220 $
Maturity 17/01/2025 (214 Days)
Parity 10 : 1
Emission price 1.45
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.88
Lowest since issue 1.22
Spread 0.03
Spread %1.96%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.7 USD
Average target price
279.2 USD
Spread / Average Target
+19.45%
Consensus